FusionNeoAntigen Logo

Home

Download

Statistics

Examples

Help

Contact

Terms of Use

Center for Computational Systems Medicine
leaf

Fusion Gene and Fusion Protein Summary

leaf

Fusion Amino Acid Sequences (multiple BPs and multiple gene isoforms)

leaf

Fusion Protein Breakpoint Sequences - (for the Screening of the FusionNeoAntigens)

leaf

Potential FusionNeoAntigens in HLA I - (netMHCpan v4.1 + deepHLApan v1.1)

leaf

Potential FusionNeoAntigens in HLA II - (netMHCIIpan v4.1)

leaf

Fusion Breakpoint 14 AA Peptide Structure - (RoseTTAFold)

leaf

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D - (Glide)

leaf

Vaccine Design for the FusionNeoAntigens (RNA/protein sequences)

leaf

Potential target of CAR-T therapy development

leaf

Information on the samples that have these potential fusion neoantigens

leaf

Fusion Protein Targeting Drugs - (Manual Curation)

leaf

Fusion Protein Related diseases - (Manual Curation)

Fusion Protein:BCL7A-MSI1

Fusion Gene and Fusion Protein Summary

check button Fusion gene summary
Fusion partner gene informationFusion gene name: BCL7A-MSI1
FusionPDB ID: 9437
FusionGDB2.0 ID: 9437
HgeneTgene
Gene symbol

BCL7A

MSI1

Gene ID

605

4440

Gene nameBAF chromatin remodeling complex subunit BCL7Amusashi RNA binding protein 1
SynonymsBCL7-
Cytomap

12q24.31

12q24.31

Type of geneprotein-codingprotein-coding
DescriptionB-cell CLL/lymphoma 7 protein family member AB-cell CLL/lymphoma 7AB-cell CLL/lymphoma-7BCL tumor suppressor 7ABCL7A, BAF complex componentRNA-binding protein Musashi homolog 1musashi-1musashi1
Modification date2020031320200313
UniProtAcc

Q4VC05

Main function of 5'-partner protein:

O43347

Main function of 5'-partner protein: FUNCTION: RNA binding protein that regulates the expression of target mRNAs at the translation level. Regulates expression of the NOTCH1 antagonist NUMB. Binds RNA containing the sequence 5'-GUUAGUUAGUUAGUU-3' and other sequences containing the pattern 5'-[GA]U(1-3)AGU-3'. May play a role in the proliferation and maintenance of stem cells in the central nervous system (By similarity). {ECO:0000250}.
Ensembl transtripts involved in fusion geneENST idsENST00000261822, ENST00000538010, 
ENST00000546622, ENST00000257552, 
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0)* DoF score8 X 6 X 6=2884 X 4 X 5=80
# samples 96
** MAII scorelog2(9/288*10)=-1.67807190511264
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
log2(6/80*10)=-0.415037499278844
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
Fusion gene context

PubMed: BCL7A [Title/Abstract] AND MSI1 [Title/Abstract] AND fusion [Title/Abstract]

Fusion neoantigen context

PubMed: BCL7A [Title/Abstract] AND MSI1 [Title/Abstract] AND neoantigen [Title/Abstract]

Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0)BCL7A(122473333)-MSI1(120791182), # samples:1
Anticipated loss of major functional domain due to fusion event.BCL7A-MSI1 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
BCL7A-MSI1 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
BCL7A-MSI1 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
BCL7A-MSI1 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID


check button Four levels of functional features of fusion genes
Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr12:122473333/chr12:120791182)
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
- How to search
1. Put your fusion gene symbol.
2. Press the tab key until there will be shown the breakpoint information filled.
4. Go down and press 'Search' tab twice.
4. Go down to have the hyperlink of the search result.
5. Click the hyperlink.
6. See the FGviewer result for your fusion gene.
FGviewer

check buttonRetention analysis results of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features, are available here.

check buttonFusion gene breakpoints across BCL7A (5'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure

check buttonFusion gene breakpoints across MSI1 (3'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure


Top

Fusion Amino Acid Sequences


check buttonFusion information from ORFfinder translation from full-length transcript sequence from FusionPDB.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)
BP loci
(transcript)
Predicted start
(transcript)
Predicted stop
(transcript)
Seq length
(amino acids)
ENST00000538010BCL7Achr12122473333-ENST00000257552MSI1chr12120791182-5175294126703377235
ENST00000261822BCL7Achr12122473333-ENST00000257552MSI1chr12120791182-2711477206913235

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score
ENST00000538010ENST00000257552BCL7Achr12122473333-MSI1chr12120791182-0.0186786860.9813213
ENST00000261822ENST00000257552BCL7Achr12122473333-MSI1chr12120791182-0.0407967830.9592032

check button Predicted full-length fusion amino acid sequences. For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among all the predicted ones.

Get the fusion protein sequences from here.

Fusion protein sequence information is available in the fasta format.
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP

Top

Fusion Protein Breakpoint Sequences for BCL7A-MSI1

check button +/-13 AA sequence from the breakpoints of the fusion protein sequences.
HgeneHchrHbpTgeneTchrTbpLength(fusion protein)BP in fusion proteinPeptide
BCL7Achr12122473333MSI1chr12120791182294190PENSSSPGMMDMHGYPGFQATTYASR
BCL7Achr12122473333MSI1chr1212079118247790PENSSSPGMMDMHGYPGFQATTYASR

Top

Potential FusionNeoAntigen Information of BCL7A-MSI1 in HLA I

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
BCL7A-MSI1_122473333_120791182.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCpan v4.1 (%rank<0.5) and deepHLApan v1.1 (immunogenic score>0.5)
Fusion geneHchrHbpTgeneTchrTbpHLA IFusionNeoAntigen peptideBinding scoreImmunogenic scoreNeoantigen start (at BP 13)Neoantigen end (at BP 13)
BCL7A-MSI1chr12122473333chr12120791182477HLA-B39:06MHGYPGFQA0.9990.89081120
BCL7A-MSI1chr12122473333chr12120791182477HLA-B39:01MHGYPGFQA0.99750.86881120
BCL7A-MSI1chr12122473333chr12120791182477HLA-B39:06MHGYPGFQAT0.99460.93641121
BCL7A-MSI1chr12122473333chr12120791182477HLA-B35:08SPGMMDMHGY0.98670.7617515
BCL7A-MSI1chr12122473333chr12120791182477HLA-B35:01SPGMMDMHGY0.980.648515
BCL7A-MSI1chr12122473333chr12120791182477HLA-B15:01HGYPGFQATTY0.99960.92061223
BCL7A-MSI1chr12122473333chr12120791182477HLA-B15:25HGYPGFQATTY0.99960.92371223
BCL7A-MSI1chr12122473333chr12120791182477HLA-B15:02HGYPGFQATTY0.99930.93841223
BCL7A-MSI1chr12122473333chr12120791182477HLA-B46:01HGYPGFQATTY0.99730.50911223
BCL7A-MSI1chr12122473333chr12120791182477HLA-B35:08HGYPGFQATTY0.99660.88691223
BCL7A-MSI1chr12122473333chr12120791182477HLA-B35:05HGYPGFQATTY0.99630.72331223
BCL7A-MSI1chr12122473333chr12120791182477HLA-B35:01HGYPGFQATTY0.99430.88721223
BCL7A-MSI1chr12122473333chr12120791182477HLA-B39:05MHGYPGFQA0.99540.85241120
BCL7A-MSI1chr12122473333chr12120791182477HLA-B73:01MHGYPGFQA0.20420.93541120
BCL7A-MSI1chr12122473333chr12120791182477HLA-B15:07HGYPGFQATTY0.99930.82511223
BCL7A-MSI1chr12122473333chr12120791182477HLA-B15:21HGYPGFQATTY0.99930.90591223
BCL7A-MSI1chr12122473333chr12120791182477HLA-B15:05HGYPGFQATTY0.99680.88341223
BCL7A-MSI1chr12122473333chr12120791182477HLA-B15:31HGYPGFQATTY0.99490.88871223
BCL7A-MSI1chr12122473333chr12120791182477HLA-B15:09MHGYPGFQA0.9750.95431120
BCL7A-MSI1chr12122473333chr12120791182477HLA-B35:77SPGMMDMHGY0.980.648515
BCL7A-MSI1chr12122473333chr12120791182477HLA-B35:23SPGMMDMHGY0.97920.661515
BCL7A-MSI1chr12122473333chr12120791182477HLA-B15:11SPGMMDMHGY0.87760.6862515
BCL7A-MSI1chr12122473333chr12120791182477HLA-B15:27HGYPGFQATTY0.99970.94361223
BCL7A-MSI1chr12122473333chr12120791182477HLA-B15:135HGYPGFQATTY0.99960.93341223
BCL7A-MSI1chr12122473333chr12120791182477HLA-B15:39HGYPGFQATTY0.99960.89441223
BCL7A-MSI1chr12122473333chr12120791182477HLA-B15:50HGYPGFQATTY0.99960.94261223
BCL7A-MSI1chr12122473333chr12120791182477HLA-B15:08HGYPGFQATTY0.99960.89411223
BCL7A-MSI1chr12122473333chr12120791182477HLA-B15:125HGYPGFQATTY0.99960.92061223
BCL7A-MSI1chr12122473333chr12120791182477HLA-B15:33HGYPGFQATTY0.99960.92061223
BCL7A-MSI1chr12122473333chr12120791182477HLA-B15:34HGYPGFQATTY0.99960.92061223
BCL7A-MSI1chr12122473333chr12120791182477HLA-B35:43HGYPGFQATTY0.99950.8961223
BCL7A-MSI1chr12122473333chr12120791182477HLA-B15:11HGYPGFQATTY0.99950.89881223
BCL7A-MSI1chr12122473333chr12120791182477HLA-B35:11HGYPGFQATTY0.99930.90671223
BCL7A-MSI1chr12122473333chr12120791182477HLA-B15:35HGYPGFQATTY0.99920.93121223
BCL7A-MSI1chr12122473333chr12120791182477HLA-B35:30HGYPGFQATTY0.9970.82771223
BCL7A-MSI1chr12122473333chr12120791182477HLA-B35:17HGYPGFQATTY0.9970.82771223
BCL7A-MSI1chr12122473333chr12120791182477HLA-B15:20HGYPGFQATTY0.99670.91771223
BCL7A-MSI1chr12122473333chr12120791182477HLA-B35:28HGYPGFQATTY0.99470.94171223
BCL7A-MSI1chr12122473333chr12120791182477HLA-B35:77HGYPGFQATTY0.99430.88721223
BCL7A-MSI1chr12122473333chr12120791182477HLA-B35:23HGYPGFQATTY0.99390.90381223
BCL7A-MSI1chr12122473333chr12120791182477HLA-B35:20HGYPGFQATTY0.99320.94871223
BCL7A-MSI1chr12122473333chr12120791182477HLA-C03:02HGYPGFQATTY0.97670.96671223
BCL7A-MSI1chr12122473333chr12120791182477HLA-B35:24HGYPGFQATTY0.97470.86831223

Top

Potential FusionNeoAntigen Information of BCL7A-MSI1 in HLA II

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
BCL7A-MSI1_122473333_120791182.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCIIpan v4.1 (%rank<0.5).
Fusion geneHchrHbpTgeneTchrTbpHLA IIFusionNeoAntigen peptideNeoantigen start (at BP 13)Neoantigen end (at BP 13)
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1501MMDMHGYPGFQATTY823
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1501GMMDMHGYPGFQATT722
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1501MDMHGYPGFQATTYA924
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1501PGMMDMHGYPGFQAT621
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1502MMDMHGYPGFQATTY823
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1502GMMDMHGYPGFQATT722
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1503MMDMHGYPGFQATTY823
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1503GMMDMHGYPGFQATT722
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1504MMDMHGYPGFQATTY823
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1504GMMDMHGYPGFQATT722
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1504MDMHGYPGFQATTYA924
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1504PGMMDMHGYPGFQAT621
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1505MMDMHGYPGFQATTY823
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1505GMMDMHGYPGFQATT722
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1505MDMHGYPGFQATTYA924
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1505PGMMDMHGYPGFQAT621
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1506MMDMHGYPGFQATTY823
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1506GMMDMHGYPGFQATT722
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1506MDMHGYPGFQATTYA924
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1506PGMMDMHGYPGFQAT621
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1507MMDMHGYPGFQATTY823
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1507GMMDMHGYPGFQATT722
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1507MDMHGYPGFQATTYA924
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1507PGMMDMHGYPGFQAT621
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1508MMDMHGYPGFQATTY823
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1508GMMDMHGYPGFQATT722
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1509MMDMHGYPGFQATTY823
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1509GMMDMHGYPGFQATT722
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1509MDMHGYPGFQATTYA924
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1509PGMMDMHGYPGFQAT621
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1510MMDMHGYPGFQATTY823
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1510GMMDMHGYPGFQATT722
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1511MMDMHGYPGFQATTY823
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1511GMMDMHGYPGFQATT722
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1512MMDMHGYPGFQATTY823
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1512GMMDMHGYPGFQATT722
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1513MMDMHGYPGFQATTY823
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1513GMMDMHGYPGFQATT722
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1513MDMHGYPGFQATTYA924
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1513PGMMDMHGYPGFQAT621
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1514MMDMHGYPGFQATTY823
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1514GMMDMHGYPGFQATT722
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1515MMDMHGYPGFQATTY823
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1515GMMDMHGYPGFQATT722
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1516MMDMHGYPGFQATTY823
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1516GMMDMHGYPGFQATT722
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1516MDMHGYPGFQATTYA924
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1516PGMMDMHGYPGFQAT621
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1518MMDMHGYPGFQATTY823
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1518GMMDMHGYPGFQATT722
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1518MDMHGYPGFQATTYA924
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1518PGMMDMHGYPGFQAT621
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1519MMDMHGYPGFQATTY823
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1519GMMDMHGYPGFQATT722
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1520MMDMHGYPGFQATTY823
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1520GMMDMHGYPGFQATT722
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1520MDMHGYPGFQATTYA924
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1520PGMMDMHGYPGFQAT621
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1521MMDMHGYPGFQATTY823
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1522MMDMHGYPGFQATTY823
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1522GMMDMHGYPGFQATT722
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1522MDMHGYPGFQATTYA924
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1522PGMMDMHGYPGFQAT621
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1524MMDMHGYPGFQATTY823
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1524GMMDMHGYPGFQATT722
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1524MDMHGYPGFQATTYA924
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1524PGMMDMHGYPGFQAT621
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1526MMDMHGYPGFQATTY823
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1526GMMDMHGYPGFQATT722
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1528MMDMHGYPGFQATTY823
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1528GMMDMHGYPGFQATT722
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1528MDMHGYPGFQATTYA924
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1528PGMMDMHGYPGFQAT621
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1530MMDMHGYPGFQATTY823
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1530GMMDMHGYPGFQATT722
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1531MMDMHGYPGFQATTY823
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1531GMMDMHGYPGFQATT722
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1532MMDMHGYPGFQATTY823
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1532GMMDMHGYPGFQATT722
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1532MDMHGYPGFQATTYA924
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1532PGMMDMHGYPGFQAT621
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1533MMDMHGYPGFQATTY823
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1533GMMDMHGYPGFQATT722
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1533MDMHGYPGFQATTYA924
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1533PGMMDMHGYPGFQAT621
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1535MMDMHGYPGFQATTY823
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1535GMMDMHGYPGFQATT722
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1535MDMHGYPGFQATTYA924
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1535PGMMDMHGYPGFQAT621
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1536MMDMHGYPGFQATTY823
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1536GMMDMHGYPGFQATT722
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1536MDMHGYPGFQATTYA924
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1536PGMMDMHGYPGFQAT621
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1537MMDMHGYPGFQATTY823
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1537GMMDMHGYPGFQATT722
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1537MDMHGYPGFQATTYA924
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1537PGMMDMHGYPGFQAT621
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1538MMDMHGYPGFQATTY823
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1538GMMDMHGYPGFQATT722
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1539MMDMHGYPGFQATTY823
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1539GMMDMHGYPGFQATT722
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1540MMDMHGYPGFQATTY823
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1540GMMDMHGYPGFQATT722
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1540MDMHGYPGFQATTYA924
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1540PGMMDMHGYPGFQAT621
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1541MMDMHGYPGFQATTY823
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1541GMMDMHGYPGFQATT722
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1541MDMHGYPGFQATTYA924
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1541PGMMDMHGYPGFQAT621
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1542MMDMHGYPGFQATTY823
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1542GMMDMHGYPGFQATT722
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1542MDMHGYPGFQATTYA924
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1542PGMMDMHGYPGFQAT621
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1543MMDMHGYPGFQATTY823
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1543GMMDMHGYPGFQATT722
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1543MDMHGYPGFQATTYA924
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1543PGMMDMHGYPGFQAT621
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1544MMDMHGYPGFQATTY823
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1544GMMDMHGYPGFQATT722
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1545MMDMHGYPGFQATTY823
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1545GMMDMHGYPGFQATT722
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1545MDMHGYPGFQATTYA924
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1545PGMMDMHGYPGFQAT621
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1546MMDMHGYPGFQATTY823
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1546GMMDMHGYPGFQATT722
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1546MDMHGYPGFQATTYA924
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1546PGMMDMHGYPGFQAT621
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1547MMDMHGYPGFQATTY823
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1547GMMDMHGYPGFQATT722
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1548MMDMHGYPGFQATTY823
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1548GMMDMHGYPGFQATT722
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1548MDMHGYPGFQATTYA924
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1548PGMMDMHGYPGFQAT621
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1549MMDMHGYPGFQATTY823
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1549GMMDMHGYPGFQATT722
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1549MDMHGYPGFQATTYA924
BCL7A-MSI1chr12122473333chr12120791182477DRB1-1549PGMMDMHGYPGFQAT621

Top

Fusion breakpoint peptide structures of BCL7A-MSI1

check button3D structures of the fusion breakpoint peptide of 14AA sequence that have potential fusion neoantigens
* The minimum length of the amino acid sequence in RoseTTAFold is 14AA. Here, we predicted the 14AA fusion protein breakpoint sequence not the fusion neoantigen peptide, which is shorter than 14 AA.
File nameBPseqHgeneTgeneHchrHbpTchrTbpAAlen
6658PGMMDMHGYPGFQABCL7AMSI1chr12122473333chr12120791182477

Top

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D of BCL7A-MSI1

check buttonVirtual screening between 25 HLAs (from PDB) and FusionNeoAntigens
* We used Glide to predict the interaction between HLAs and neoantigens.
HLA allelePDB IDFile nameBPseqDocking scoreGlide score
HLA-B14:023BVN6658PGMMDMHGYPGFQA-7.15543-7.26883
HLA-B14:023BVN6658PGMMDMHGYPGFQA-4.77435-5.80965
HLA-B52:013W396658PGMMDMHGYPGFQA-6.80875-6.92215
HLA-B52:013W396658PGMMDMHGYPGFQA-4.20386-5.23916
HLA-A11:014UQ26658PGMMDMHGYPGFQA-7.5194-8.5547
HLA-A11:014UQ26658PGMMDMHGYPGFQA-6.9601-7.0735
HLA-A24:025HGA6658PGMMDMHGYPGFQA-7.52403-7.63743
HLA-A24:025HGA6658PGMMDMHGYPGFQA-5.82433-6.85963
HLA-B27:056PYJ6658PGMMDMHGYPGFQA-3.28285-4.31815
HLA-B44:053DX86658PGMMDMHGYPGFQA-5.91172-6.94702
HLA-B44:053DX86658PGMMDMHGYPGFQA-4.24346-4.35686

Top

Vaccine Design for the FusionNeoAntigens of BCL7A-MSI1

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-Is.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptide sequenceFusionNeoAntigen RNA sequence
BCL7A-MSI1chr12122473333chr121207911821120MHGYPGFQATGCATGGTTACCCAGGTTTCCAAGCCA
BCL7A-MSI1chr12122473333chr121207911821121MHGYPGFQATTGCATGGTTACCCAGGTTTCCAAGCCACAA
BCL7A-MSI1chr12122473333chr121207911821223HGYPGFQATTYATGGTTACCCAGGTTTCCAAGCCACAACCTACG
BCL7A-MSI1chr12122473333chr12120791182515SPGMMDMHGYCCCCAGGGATGATGGACATGCATGGTTACC

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-IIs.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptideFusionNEoAntigen RNA sequence
BCL7A-MSI1chr12122473333chr12120791182621PGMMDMHGYPGFQATCAGGGATGATGGACATGCATGGTTACCCAGGTTTCCAAGCCACAA
BCL7A-MSI1chr12122473333chr12120791182722GMMDMHGYPGFQATTGGATGATGGACATGCATGGTTACCCAGGTTTCCAAGCCACAACCT
BCL7A-MSI1chr12122473333chr12120791182823MMDMHGYPGFQATTYTGATGGACATGCATGGTTACCCAGGTTTCCAAGCCACAACCTACG
BCL7A-MSI1chr12122473333chr12120791182924MDMHGYPGFQATTYATGGACATGCATGGTTACCCAGGTTTCCAAGCCACAACCTACGCCA

Top

Information of the samples that have these potential fusion neoantigens of BCL7A-MSI1

check button These samples were reported as having these fusion breakpoints. For individual breakpoints, we checked the open reading frames considering multiple gene isoforms and chose the in-frame fusion genes only. Then, we made fusion protein sequences and predicted the fusion neoantigens. These fusion-positive samples may have these potential fusion neoantigens.
Cancer typeFusion geneHchrHbpHenstTchrTbpTenstSample
STADBCL7A-MSI1chr12122473333ENST00000261822chr12120791182ENST00000257552TCGA-CG-4444-01A

Top

Potential target of CAR-T therapy development for BCL7A-MSI1

check button Predicted 3D structure. We used RoseTTAFold.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, to provide the retention of the transmembrane domain, we only show the protein feature retention information of those transmembrane features


* Minus value of BPloci means that the break point is located before the CDS.
- In-frame and retained 'Transmembrane'.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note

check button Subcellular localization prediction of the transmembrane domain retained fusion proteins
* We used DeepLoc 1.0. The order of the X-axis of the barplot is as follows: Entry_ID, Localization, Type, Nucleus, Cytoplasm, Extracellular, Mitochondrion, Cell_membrane, Endoplasmic_reticulum, Plastid, Golgi.apparatus, Lysosome.Vacuole, Peroxisome. Y-axis is the output score of DeepLoc. Clicking the image will open a new tab with a large image.
HgeneHchrHbpHenstTgeneTchrTbpTenstDeepLoc result

Top

Related Drugs to BCL7A-MSI1

check button Drugs used for this fusion-positive patient.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDrugSourcePMID

Top

Related Diseases to BCL7A-MSI1

check button Diseases that have this fusion gene.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDiseaseSourcePMID

check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource